On Monday, Kalaris Therapeutics Inc (NASDAQ: KLRS) was 20.93% up from the session before settling in for the closing price of $6.64. A 52-week range for KLRS has been $2.14 – $24.15.
Annual sales at Healthcare sector company slipped by -6.86% over the past five years. When this article was written, the company’s average yearly earnings per share was at 73.70%. With a float of $4.75 million, this company’s outstanding shares have now reached $18.70 million.
Kalaris Therapeutics Inc (KLRS) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Kalaris Therapeutics Inc stocks. The insider ownership of Kalaris Therapeutics Inc is 74.58%, while institutional ownership is 7.07%. The most recent insider transaction that took place on Mar 26 ’25, was worth 8,135. In this transaction Chief Accounting Officer of this company sold 907 shares at a rate of $8.97, taking the stock ownership to the 1,925 shares.
Kalaris Therapeutics Inc (KLRS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 55.30% during the next five years compared to -6.86% drop over the previous five years of trading.
Kalaris Therapeutics Inc (NASDAQ: KLRS) Trading Performance Indicators
You can see what Kalaris Therapeutics Inc (KLRS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 11.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.58, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -2.17 in one year’s time.
Technical Analysis of Kalaris Therapeutics Inc (KLRS)
Kalaris Therapeutics Inc (NASDAQ: KLRS) saw its 5-day average volume 0.27 million, a positive change from its year-to-date volume of 0.13 million. As of the previous 9 days, the stock’s Stochastic %D was 78.71%.
During the past 100 days, Kalaris Therapeutics Inc’s (KLRS) raw stochastic average was set at 88.37%, which indicates a significant increase from 83.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.86 in the past 14 days, which was higher than the 0.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.87, while its 200-day Moving Average is $6.05. Nevertheless, the first resistance level for the watch stands at $9.01 in the near term. At $9.99, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.18. If the price goes on to break the first support level at $6.84, it is likely to go to the next support level at $5.66. Assuming the price breaks the second support level, the third support level stands at $4.68.
Kalaris Therapeutics Inc (NASDAQ: KLRS) Key Stats
There are 18,702K outstanding shares of the company, which has a market capitalization of 134.41 million. As of now, sales total 0 K while income totals -58,770 K. Its latest quarter income was 0 K while its last quarter net income were -11,350 K.
